Filing Flows

Filing Flows › Arcus Biosciences (RCUS) › Who owns the stock

Who owns Arcus Biosciences (RCUS) stock

215 funds reported Arcus Biosciences (RCUS) shares in their latest 13F filings, worth $3.9B in all. The largest holder is Gilead Sciences ($969M). Last quarter 117 funds added to their stakes and 77 cut them.

Largest holders of RCUS (13F)Largest holders of RCUS (13F)Gilead Sciences$969MBlackRock$506MVanguard Group$190MState Street$186MWellington Management Group LLP$182MSuvretta Capital Management, LLC$147MVanguard Portfolio Management LLC$138MFMR LLC$125MVanguard Capital Management LLC$120MCitadel Advisors LLC$96.7M

Largest holders (13F)

FundSharesValueChangeQuarter
Gilead Sciences31,424,760$969Munchanged2026-06-30
BlackRock16,416,249$506Mincrease2026-06-30
Vanguard Group7,962,874$190Mincrease2025-12-31
State Street6,029,484$186Mincrease2026-06-30
Wellington Management Group LLP5,895,448$182Mdecrease2026-06-30
Suvretta Capital Management, LLC4,776,423$147Mdecrease2026-06-30
Vanguard Portfolio Management LLC4,475,528$138Mincrease2026-06-30
FMR LLC4,049,757$125Mincrease2026-06-30
Vanguard Capital Management LLC3,888,346$120Mincrease2026-06-30
Citadel Advisors LLC3,135,057$96.7Mincrease2026-06-30
Woodline Partners LP3,007,798$92.7Mdecrease2026-06-30
Geode Capital Management, LLC2,448,749$75.5Mincrease2026-06-30
Siren, L.L.C.2,420,430$74.6Mdecrease2026-06-30
Fisher Asset Management, LLC2,139,396$66.0Mdecrease2026-06-30
Marshall Wace, LLP1,945,088$60.0Mdecrease2026-06-30

Arcus Biosciences' latest quarter

Arcus Biosciences, Q3 2026: revenue $9.0M (-65% year over year), net loss $128M, operating cash flow −$88.0M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most RCUS stock?

By the latest 13F filings: Gilead Sciences ($969M); BlackRock ($506M); Vanguard Group ($190M); State Street ($186M); Wellington Management Group LLP ($182M).

What is the short interest in RCUS?

12,358,588 shares were sold short at the 2026-10-15 settlement, -5.74% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.